Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 8

1.

Neuroprotective effects of mesenchymal stem cells derived from human embryonic stem cells in transient focal cerebral ischemia in rats.

Liu YP, Seçkin H, Izci Y, Du ZW, Yan YP, Başkaya MK.

J Cereb Blood Flow Metab. 2009 Apr;29(4):780-91. doi: 10.1038/jcbfm.2009.1.

PMID:
19209181
2.

Improving outcome of transplanted mesenchymal stem cells for ischemic heart disease.

Shi RZ, Li QP.

Biochem Biophys Res Commun. 2008 Nov 14;376(2):247-50. doi: 10.1016/j.bbrc.2008.09.004. Review.

PMID:
18789897
3.

[Mesenchymal progenitor cells. Biological characteristic and prospects for their use].

Sukhikh GT, Spivak NIa, Malaĭtsev VV, Bogdanova IM, Shevchuk VA.

Fiziol Zh. 2007;53(1):62-76. Review. Russian.

PMID:
17500204
4.

[Origin of mesenchymal stem cells].

Era T, Takashima Y, Nishikawa S.

Tanpakushitsu Kakusan Koso. 2008 Jan;53(1):59-64. Review. Japanese. No abstract available.

PMID:
18186304
5.

Mesenchymal stem cells.

Roberts I.

Vox Sang. 2004 Jul;87 Suppl 2:38-41. Review. No abstract available.

PMID:
15209876
6.

Control of cell fate decisions.

Cool SM.

J Mol Histol. 2007 Oct;38(5):377-9. Review. No abstract available.

PMID:
17957488
7.

Yet another role for mesenchmyal stem cells?

Newsome P.

Transplantation. 2008 Jun 15;85(11):1548-9. doi: 10.1097/TP.0b013e318173a47f. Review. No abstract available.

PMID:
18551057
8.

Engineered adenosine-releasing cells for epilepsy therapy: human mesenchymal stem cells and human embryonic stem cells.

Boison D.

Neurotherapeutics. 2009 Apr;6(2):278-83. doi: 10.1016/j.nurt.2008.12.001. Review.

Supplemental Content

Support Center